Holen Sie sich die Stockscreener-App
25.41
0.24%
-0.02
Handel nachbörslich:
25.41
Finanzdaten der Enliven Therapeutics Inc-Aktie (ELVN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
14.33%
25.99
|
22.73 | 24.25 | 20.13 | 16.42 |
| Operating Income/Loss |
14.33%
-25.99
|
-22.73 | -24.25 | -20.13 | -16.42 |
| Nonoperating Income/Loss |
3.27%
3.249
|
3.359 | 3.479 | 3.413 | 1.694 |
| Income/Loss From Continuing Operations Before Tax |
17.39%
-22.74
|
-19.37 | -20.77 | -16.72 | -14.72 |
| Income/Loss From Continuing Operations After Tax |
17.39%
-22.74
|
-19.37 | -20.77 | -16.72 | -14.72 |
|
Net Income/Loss
|
17.39%
-22.74
|
-19.37 | -20.77 | -16.72 | -14.72 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
2,135%
42.05
|
1.8811 | 41.03 | 40.96 | 18.51 |
| Diluted Average Shares |
2,135%
42.05
|
1.8811 | 41.03 | 40.96 | 18.51 |
| Basic Earnings Per Share |
17.39%
-0.54
|
-0.46 | -0.51 | -0.41 | -0.80 |
| Diluted Earnings Per Share |
17.39%
-0.54
|
-0.46 | -0.51 | -0.41 | -0.80 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.93%
3.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):